Strides Pharma Science informs about press release

22 Dec 2022 Evaluate
Strides Pharma Science has informed that it enclosed press release ‘Receipt of AUD 94 million on account of deferred consideration on the sale of the Company’s Australian operations in 2019’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

922.00 22.25 (2.47%)
11-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1499.50
Dr. Reddys Lab 6052.35
Cipla 1529.85
Zydus Lifesciences 1084.75
Lupin 1614.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.